Application value of lithium carbonate for the low uptake rate of 131I treatment in patients with Graves
-
Received Date:
2009-10-23
-
Abstract
Objective To observe 131I uptake rate of Graves's patients after taking lithium carbonate thyroid and to investigate application value of lithium carbonate for the low 131I uptake rate in Graves's patients. Methods Forty-six low 131I uptake Graves's patients take lithium carbonate orally after meal, three times daily, 250 mg each time, and served 10 days, detected 131I uptake rate respectively before and after lithium carbonate treatment and compared the changes. Result Low 131I uptake rate after intake of lithium carbonate with 10 days was significantly higher(27%)in 24 hours than before with a statistic difference(t=3.24, P < 0.01). Conclusions Lithium carbonate can improved the intake of thyroid 131I Graves's patients, met the requirements of patients and reduced the amount of 131I treatment.So it was valuable for clinical application.
-
-
References
[1]
|
Koong SS, Reynolds JC, Movius EG, et al. Lithium as a potential adjuvant to 131I therapy of metastatic, well differentiated thyroid carcinoma. J Clin Endocrinol Metab, 1999, 84(3): 912-916. |
[2]
|
康玉国, 匡安仁, 陈淼. 碳酸锂在131I治疗Graves病中的应用. 同位素, 2004, 17(1): 59-61. |
[3]
|
张承刚. 甲状腺疾病核素治疗学. 北京: 原子能出版社, 2003: 181. |
[4]
|
Bogazzi F, Bartalena L, Brogioni S, et al. Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves'hyperthyroidism. J Clin Endocrinol Metab, 1999, 84(2): 499-503. |
-
-
Proportional views
-